Two of the top multi-state operators have seen their shares jump since reclassifying news came out, but they may no longer be the best cannabis stocks to buy.
Cannabis company Green Thumb is younger and in a different sector than consumer staples giant Procter & Gamble, but it's succeeding with similar methods.
In a paradoxical display of market confidence, shares of Tilray Brands (NASDAQ:TLRY) surged over 8% on Wednesday following the release of its fiscal third-quarter 2026 financial results. While the company delivered a "record" revenue performance of $206.7 million, outstripping analyst estimates of $201.3 million, it fell significantly
As of January 9, 2026, the cannabis sector finds itself at a historic crossroads, caught between the euphoria of federal progress and the harsh reality of market mechanics. Following a landmark Executive Order in late 2025 aimed at accelerating the rescheduling of marijuana, the industry has entered the new year
The cannabis sector is experiencing a historic "Santa Claus rally" this December, with stock prices surging across the board following a transformative shift in federal policy. Today, December 19, 2025, markets are still reeling from yesterday’s decisive executive action aimed at ending the federal gridlock that has plagued the
In a move that has sent shockwaves through the global financial markets, the cannabis sector is currently navigating a period of unprecedented volatility following a landmark regulatory shift. On December 18, 2025, President Donald Trump signed a historic Executive Order directing the Attorney General to expedite the reclassification of marijuana
Congress appears set to end the record-long government shutdown, but a controversial provision tucked into the spending bill is sparking alarm across the hemp and cannabis industry.
